CervoMed Reports Q3 2026 Net Loss of $5.9 Million
CervoMed reported a third-quarter 2026 net loss of approximately $5.9 million, down from $7.7 million a year earlier. It ended September with $19.6 million in cash, cash equivalents and marketable securities, and said resources are expected to fund planned operations through Q3 2027.
CervoMed reported a third-quarter 2026 net loss of approximately $5.9 million, down from $7.7 million a year earlier, and ended September with $19.6 million in cash, cash equivalents and marketable securities. The company said its current resources are expected to fund planned operations through th…